HNB
IPXL

Huntington National Bank’s Impax Laboratories, Inc. IPXL Stock Holding History

Huntington National Bank’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,764
Closed -$223K – 1783
2016
Q1 		$223K Buy
+4,764
New +$167K 0.01% 612
2015
Q2 		– Sell
-4,764
Closed -$223K – 1863
2015
Q1 		$223K Sell
4,764
-2,017
-30% -$80.3K 0.01% 615
2014
Q4 		$215K Buy
+6,781
New +$198K 0.01% 642

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Huntington National Bank's IPXL Position: Q2 2016 in Review

Huntington National Bank sold out of Impax Laboratories, Inc. (IPXL) in Q2 2016, closing a stake of 4,764 shares — an estimated $223K sold.

Huntington National Bank first reported a position in IPXL in Q4 2014 and held it in 3 quarters. The position peaked at $223K in Q1 2016. 198 funds tracked by Wall St. Rank hold IPXL as of Q2 2016.

  • Huntington National Bank reported no remaining Impax Laboratories, Inc. position as of Q2 2016 after selling out during the quarter.
  • Huntington National Bank sold 4,764 Impax Laboratories, Inc. shares in Q2 2016, an estimated $223K.
  • Huntington National Bank first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 3 quarters.
  • Huntington National Bank's Impax Laboratories, Inc. position peaked at $223K in Q1 2016.
  • 198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2016.

Based on Huntington National Bank's 13F filing for Q2 2016, filed 25 Jul 2016.